BioLife Solutions, Inc.
BLFS
$20.12
-$0.55-2.66%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.67M | -3.21M | -5.53M | 10.31M | 535.00K |
| Total Depreciation and Amortization | 4.10M | 5.81M | 6.79M | 5.41M | 6.30M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.43M | 20.05M | 18.33M | -3.41M | -1.86M |
| Change in Net Operating Assets | -6.67M | -5.81M | -4.04M | -4.13M | -3.01M |
| Cash from Operations | 15.20M | 16.84M | 15.54M | 14.63M | 8.43M |
| Capital Expenditure | -6.01M | -6.81M | -4.68M | -2.78M | -3.17M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -66.67M | 7.77M | 9.93M | 47.56M | 74.91M |
| Cash from Investing | -72.68M | 961.00K | 5.25M | 31.35M | 58.30M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.50M | -10.93M | -11.14M | -8.64M | -6.38M |
| Issuance of Common Stock | 18.00K | 83.00K | 129.00K | 111.00K | 111.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -946.00K | -1.67M | 14.00K | 410.00K | 191.00K |
| Cash from Financing | -8.43M | -12.51M | -11.00M | -8.82M | -6.78M |
| Foreign Exchange rate Adjustments | -- | 29.00K | 65.00K | 65.00K | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -65.91M | 5.32M | 9.86M | 37.22M | 59.95M |